Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The latest news from Arcinova

July 16, 2020

Arcinova appoints new Non-Executive Director

Arcinova appoints new Non-Executive Director “Internationally renowned Industry veteran Steve Bagshaw joins Arcinova board to propel continued industry-leading growth” Arcinova
July 16, 2020

Nathalie Huther Featured In European Biotechnology Magazine_a

Nathalie Huther Featured In European Biotechnology Magazine Did you see Nathalie’s quote on why she chose to work in Biotechnology in the latest summer edition of
July 9, 2020

The Growing Popularity of Capsule Manufacturing in Pharma

Our Head of Drug Product and Scientific Direction, Steve Byard, recently shared his thoughts on the benefits of capsule manufacturing. In his article for PMPS, Steve explains the factors that must
June 23, 2020

OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate"

OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate" About the EventThis digi
June 4, 2020

Dr. Nathalie Huther interviewed for Chemicals Knowledge Hub TV

Our Senior Director of Business Development Europe, Dr. Nathalie Huther, was recently interviewed by journalist and presenter, David McClelland, for Chemicals Knowledge Hub TV! Watch the video to
June 1, 2020

Revving Up for the Revolution: Industry 4.0

Revving Up for the Revolution: Industry 4.0 “The current change – from the third to the fourth industrial revolution – is marked by a move toward a consolidated, full-spectrum, data-driven a
June 1, 2020

Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success

Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success Preformulation characterization of new chemical entities (NCE) can be c
June 1, 2020

Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product

We are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.
April 2, 2020

Arcinova wins BVCA Yorkshire and North East business awards - Business Transformation Management Team

Exciting news - we have won the Business Transformation Management Team title at the British Private Equity & Venture Capital Association (BVCA)’s Yorkshire and North East Management Team Aw




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH